hydralazine and ng-nitroarginine methyl ester

hydralazine has been researched along with ng-nitroarginine methyl ester in 37 studies

Research

Studies (37)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (24.32)	18.2507
2000's	20 (54.05)	29.6817
2010's	7 (18.92)	24.3611
2020's	1 (2.70)	2.80

Authors

Authors	Studies
Egashira, K; Kadokami, T; Numaguchi, K; Shimokawa, H; Sueishi, K; Takemoto, M; Takeshita, A	1
Adams, ML; Cicero, TJ; Meyer, ER; Sewing, BN	1
Howe, PR; Jablonskis, LT	1
Filep, JG	1
Anderson, IK; Drew, GM	1
Andoh, TF; Bennett, WM; Couser, WG; Johnson, RJ; Pichler, RH; Shankland, SJ; Thomas, SE	1
Bauersachs, J; Bouloumié, A; Busse, R; Ertl, G; Fraccarollo, D; Hu, K	1
Artuso, A; Benahmed, S; Casellas, D; Jover, B	1
Anderson, NH; Devlin, AM; Dominiczak, AF; Graham, D; Hamilton, CA; Morton, JJ; Reid, JL; Schork, NJ	1
Chishima, S; Egashira, K; Katoh, M; Mitsui, T; Narita, H; Takeshita, A	1
Artuso, A; Bouriquet, N; Casellas, D	1
Asanuma, H; Hori, M; Kitakaze, M; Kuzuya, T; Minamino, T; Ogai, A; Papst, PJ; Sakata, Y; Terada, N; Ueda, Y	1
Egashira, K; Inoue, S; Kaibuchi, K; Kataoka, C; Kitamoto, S; Koyanagi, M; Ni, W; Shimokawa, H; Takemoto, M; Takeshita, A; Usui, M	1
Gorny, D; Henrion, D; Kubis, N; Lévy, BI; Loufrani, L	1
Akishita, M; Imai, Y; Ishibashi, S; Kangawa, K; Kurihara, H; Kurihara, Y; Maekawa, H; Maemura, K; Minamino, N; Morita, H; Nagai, R; Oh-hashi, Y; Osuga, J; Saito, Y; Sata, M; Shindo, T; Suzuki, T; Tobe, K; Yazaki, Y	1
Asakura, M; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Liao, Y; Minamino, T; Node, K; Ogai, A; Ogita, H; Sanada, S; Takashima, S	1
Bauer, WR; Bauersachs, J; Ertl, G; Fraccarollo, D; Galuppo, P; Haase, A; Hiller, KH; Hu, K; Nahrendorf, M; Schweizer, G	1
Asakura, M; Asanuma, H; Hori, M; Kitakaze, M; Minamino, T; Node, K; Ogita, H; Sanada, S; Takashima, S	1
Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Lu, Y; Placier, S; Stefanski, A	1
de Moura, RS; Ferraz, MM; Ferraz, MR; Santos, R	1
Brooks, VL; McKeogh, DF; O'Donaughy, TL	1
Hirooka, Y; Ito, K; Kaibuchi, K; Kimura, Y; Kishi, T; Shimokawa, H; Takeshita, A	1
Henrion, D; Loufrani, L	1
Bell, D; Devine, AB; McDermott, BJ; McHenry, EM; Nicholls, DP; Smith, LR; Zhao, L; Zhao, Y	1
Kim, J; Kitakaze, M; Minamino, T; Mochizuki, N; Myoishi, M; Okada, K; Okazaki, H; Takashima, S; Tsukamoto, O; Wakeno, M	1
Abe, S; Ishihara, M; Ishizawa, K; Izawa, Y; Kanematsu, Y; Kawazoe, K; Motobayashi, Y; Ohnishi, H; Tamaki, T; Tsuchiya, K	1
Basile, DP; Frisbee, JC; Samora, JB	1
Barron, C; Gokina, N; Mandala, M; Osol, G	1
Agharazii, M; Bélanger, S; Larivière, R; Lebel, M; Lemieux, P; Therrien, F	1
Baron-Menguy, C; Cousin, M; Custaud, MA; Dumont, O; Guihot, AL; Henrion, D; Loufrani, L; Subra, JF; Toutain, B; Vessières, E	1
Chatziantoniou, C; Helle, F; Iversen, BM	1
Barron, C; Mandala, M; Osol, G	1
Al-Saleh, FM; Benter, IF; Chappell, MC; Diz, DI; Raghupathy, R; Yousif, MH	1
Azegami, T; Hayashi, K; Itoh, H; Sasamura, H	1
Andrews, D; Bass, V; Gilmour, MI; King, C; Kodavanti, UP; Krantz, QT; Ledbetter, AD; Nyska, A; Richards, JE; Schladweiler, MC; Thomas, RF	1
De Mey, JG; Janssen, B; Lemkens, P; Meens, MJ; Nelissen, J; Peters, SL; Schiffers, PM; Spijkers, LJ	1
Doiron, JE; Goodchild, TT; Koul, K; LaPenna, KB; Lefer, DJ; Li, Z; Moles, K; Patel, RB; Polhemus, DJ; Shah, SJ; Sharp, TE; Wang, JS; Xia, H	1

Other Studies

37 other study(ies) available for hydralazine and ng-nitroarginine methyl ester

Article	Year
Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:6 Pt 1 Topics: Animals; Arginine; Blood Pressure; Cardiomegaly; Coronary Circulation; Coronary Vessels; Data Interpretation, Statistical; Enzyme Inhibitors; Fibrosis; Heart; Heart Rate; Histological Techniques; Hydralazine; Hypertension; Male; Microcirculation; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred WKY	1995
Effects of nitric oxide-related agents on rat testicular function. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1 Topics: Amino Acid Oxidoreductases; Animals; Arginine; Drug Interactions; Hydralazine; Isosorbide Dinitrate; Male; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Steroids; Stimulation, Chemical; Testis; Testosterone; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	1994
Plasma adrenaline responses to long-term modification of blood pressure in normotensive rats and hypertensive rats. Journal of hypertension, 1995, Volume: 13, Issue:3 Topics: Animals; Arginine; Blood Pressure; Epinephrine; Hydralazine; Hypertension; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors	1995
Endogenous endothelin modulates blood pressure, plasma volume, and albumin escape after systemic nitric oxide blockade. Hypertension (Dallas, Tex. : 1979), 1997, Volume: 30, Issue:1 Pt 1 Topics: Analysis of Variance; Animals; Antihypertensive Agents; Azepines; Blood Pressure; Bosentan; Data Interpretation, Statistical; Endothelin Receptor Antagonists; Endothelin-1; Hydralazine; Indoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Plasma Volume; Rats; Rats, Wistar; Receptor, Endothelin A; Receptor, Endothelin B; Serum Albumin; Sulfonamides; Time Factors; Vasodilator Agents	1997
Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950. British journal of pharmacology, 1997, Volume: 122, Issue:7 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Benzofurans; Blood Pressure; Cyclic GMP; Drug Interactions; Enalapril; Enzyme Inhibitors; Hydralazine; Hypertension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Purinones; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin	1997
Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney international, 1998, Volume: 53, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; Arginine; Biotin; Cyclosporine; Deoxyuracil Nucleotides; DNA Fragmentation; Enzyme Inhibitors; Fibrosis; Hydralazine; Immunosuppressive Agents; Ischemia; Kidney; Losartan; Macrophages; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Staining and Labeling	1998
Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension. European journal of pharmacology, 1998, Nov-27, Volume: 362, Issue:1 Topics: Acetylcholine; Animals; Blood Pressure; Blotting, Western; Ditiocarb; Endothelium, Vascular; Female; Guanylate Cyclase; Hydralazine; Hypertension; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Superoxide Dismutase; Superoxides	1998
Candesartan and progression of preglomerular lesions in N(G)-nitro-L-arginine methyl ester hypertensive rats. Journal of the American Society of Nephrology : JASN, 1999, Volume: 10 Suppl 11 Topics: Albuminuria; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles	1999
Telemetry for cardiovascular monitoring in a pharmacological study: new approaches to data analysis. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 33, Issue:1 Pt 2 Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Cell Nucleus; Diastole; DNA; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Indoles; Losartan; Lymphocytes; Male; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Perindopril; Rats; Rats, Inbred SHR; Systole; Telemetry; Time Factors	1999
Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. Journal of molecular and cellular cardiology, 2000, Volume: 32, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Coronary Vessels; Enzyme Inhibitors; Gene Expression; Heart Rate; Hydralazine; Imidazoles; Imidazolidines; Immunoenzyme Techniques; Male; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred WKY; Tissue Plasminogen Activator	2000
Nitric oxide and preglomerular vascular lesions in lyon spontaneously hypertensive rats. Acta physiologica Scandinavica, 2000, Volume: 168, Issue:1 Topics: Aging; Animals; Antihypertensive Agents; Azo Compounds; Coloring Agents; Drug Combinations; Enzyme Inhibitors; Hydralazine; Hypertension; Kidney Glomerulus; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred SHR; Vascular Diseases	2000
Inhibition of nitric oxide synthesis induces coronary vascular remodeling and cardiac hypertrophy associated with the activation of p70 S6 kinase in rats. Cardiovascular drugs and therapy, 2000, Volume: 14, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomegaly; Coronary Vessels; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Hydralazine; Imidazoles; Imidazolidines; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred WKY; Ribosomal Protein S6 Kinases; Sirolimus; Ventricular Remodeling	2000
Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats. Hypertension (Dallas, Tex. : 1979), 2002, Volume: 39, Issue:2 Topics: Actins; Amides; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiovascular Diseases; Chemokine CCL2; Coronary Vessels; Enzyme Inhibitors; Hydralazine; Immunohistochemistry; Inflammation; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Muscle, Smooth; Myosins; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptidyl-Dipeptidase A; Phosphorylation; Proliferating Cell Nuclear Antigen; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred WKY; rho-Associated Kinases; RNA, Messenger; Superoxide Dismutase; Tetrazoles; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1	2002
Chronic hydralazine improves flow (shear stress)-induced endothelium-dependent dilation in mouse mesenteric resistance arteries in vitro. Microvascular research, 2002, Volume: 64, Issue:1 Topics: Acetylcholine; Animals; Blood Flow Velocity; Body Weight; Cardiovascular Agents; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Indomethacin; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Pressure; Stress, Mechanical; Vasodilator Agents	2002
Resistance to neointimal hyperplasia and fatty streak formation in mice with adrenomedullin overexpression. Arteriosclerosis, thrombosis, and vascular biology, 2002, Aug-01, Volume: 22, Issue:8 Topics: Adipose Tissue; Adrenomedullin; Animals; Apolipoproteins E; Calcitonin Gene-Related Peptide; Femoral Artery; Hydralazine; Hyperplasia; Mice; Mice, Knockout; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Peptides; Tunica Intima	2002
Opening of the adenosine triphosphate-sensitive potassium channel attenuates cardiac remodeling induced by long-term inhibition of nitric oxide synthesis: role of 70-kDa S6 kinase and extracellular signal-regulated kinase. Journal of the American College of Cardiology, 2002, Sep-04, Volume: 40, Issue:5 Topics: Adenosine Triphosphate; Animals; Blood Pressure; Body Weight; Cardiomegaly; Glyburide; Hydralazine; Mitogen-Activated Protein Kinases; NG-Nitroarginine Methyl Ester; Nicorandil; Nitric Oxide; Potassium Channels; Rats; Rats, Inbred WKY; Ribosomal Protein S6 Kinases	2002
Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study. Journal of the American College of Cardiology, 2002, Nov-06, Volume: 40, Issue:9 Topics: Animals; Disease Models, Animal; Hydralazine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyridines; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling	2002
[Opening of ATP-sensitive potassium channel attenuates cardiac remodeling induced by chronic inhibition of nitric oxide synthesis]. Journal of cardiology, 2003, Volume: 41, Issue:1 Topics: Adenosine Triphosphate; Animals; Blood Pressure; Cardiomegaly; Chromans; Hydralazine; Mitogen-Activated Protein Kinases; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channels; Rats; Rats, Inbred WKY; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Ventricular Remodeling	2003
Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:5 Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Collagen; Enzyme Inhibitors; Fibrosis; Gene Expression; Glomerulosclerosis, Focal Segmental; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta	2003
Preventing L-NAME inhibitory effects on rat sexual behavior with hydralazine, isradipine or captopril co-treatment. Pharmacology, biochemistry, and behavior, 2003, Volume: 75, Issue:2 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Captopril; Drug Interactions; Ejaculation; Enzyme Inhibitors; Female; Hydralazine; Isradipine; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Sexual Behavior, Animal; Time Factors; Vasodilator Agents	2003
NO and endogenous angiotensin II interact in the generation of renal sympathetic nerve activity in conscious rats. American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:4 Topics: Angiotensin II; Animals; Blood Pressure; Diet; Enzyme Inhibitors; Heart Rate; Hydralazine; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Sprague-Dawley; Sodium, Dietary; Sympathetic Nervous System; Vasodilator Agents	2004
Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:2 Topics: Amides; Animals; Blood Pressure; Enzyme Inhibitors; Hydralazine; Hypertension; Injections; Intracellular Signaling Peptides and Proteins; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Inbred WKY; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Solitary Nucleus	2004
Vasodilator treatment with hydralazine increases blood flow in mdx mice resistance arteries without vascular wall remodelling or endothelium function improvement. Journal of hypertension, 2005, Volume: 23, Issue:10 Topics: Acetylcholine; Animals; Blood Flow Velocity; Blood Pressure; Body Weight; Calcium; Dystrophin; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; In Vitro Techniques; Male; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mutation; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Phenylephrine; Serotonin; Stress, Mechanical; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents	2005
Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension. The Journal of pharmacology and experimental therapeutics, 2006, Volume: 316, Issue:3 Topics: Adrenomedullin; Animals; Body Weight; Hydralazine; Hydrochlorothiazide; Hypertension; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Myocytes, Cardiac; Myosin Heavy Chains; Neuropeptides; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size; Peptides; Rats; Rats, Sprague-Dawley; Receptor Activity-Modifying Protein 1; Receptor Activity-Modifying Protein 2; Receptor Activity-Modifying Protein 3; Receptor Activity-Modifying Proteins; Receptors, Adrenomedullin; Receptors, Peptide; RNA, Messenger; Systole	2006
Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Enzyme Inhibitors; Heart Atria; Heart Rate; Hydralazine; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Tetrazoles; Thrombomodulin	2006
Effects of angiotensin II type 1 receptor blockade on the systemic blood nitric oxide dynamics in Nomega-nitro-L-arginine methyl ester-treated rats. Hypertension research : official journal of the Japanese Society of Hypertension, 2006, Volume: 29, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Heart Rate; Hemodynamics; Hemoglobins; Hydralazine; Hypertension; Imidazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Tetrazoles	2006
Angiostatin does not contribute to skeletal muscle microvascular rarefaction with low nitric oxide bioavailability. Microcirculation (New York, N.Y. : 1994), 2007, Volume: 14, Issue:2 Topics: Angiostatins; Animals; Arterioles; Enzyme Inhibitors; Hydralazine; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Zucker; Regional Blood Flow; Vascular Endothelial Growth Factor A; Vascular Resistance; Vasodilator Agents	2007
Inhibition of nitric oxide synthases abrogates pregnancy-induced uterine vascular expansive remodeling. Journal of vascular research, 2009, Volume: 46, Issue:5 Topics: Animals; Arteries; Blood Pressure; Enzyme Inhibitors; Female; Fertility; Hydralazine; Hypertension, Pregnancy-Induced; Myometrium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pregnancy; Rats; Rats, Sprague-Dawley; Vascular Resistance; Vasodilator Agents	2009
Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. European journal of pharmacology, 2009, Apr-01, Volume: 607, Issue:1-3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atrasentan; Blood Pressure; Endothelin-1; Hydralazine; Hypertension, Malignant; Losartan; Male; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Insufficiency	2009
Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 55, Issue:1 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Flow Velocity; Blotting, Western; Butadienes; Cyclic N-Oxides; Extracellular Signal-Regulated MAP Kinases; Hydralazine; Male; Mesenteric Arteries; Mice; Mice, Knockout; Microscopy, Confocal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitriles; Perindopril; Rats; Rats, Wistar; Reactive Oxygen Species; Spin Labels; Tetrazoles; Vascular Resistance; Vasodilator Agents	2010
Losartan increases NO release in afferent arterioles during regression of L-NAME-induced renal damage. American journal of physiology. Renal physiology, 2010, Volume: 298, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Disease Models, Animal; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Kidney; Kidney Diseases; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Vasoconstriction	2010
Effects of pregnancy, hypertension and nitric oxide inhibition on rat uterine artery myogenic reactivity. Journal of vascular research, 2010, Volume: 47, Issue:6 Topics: Animals; Blood Pressure; Disease Models, Animal; Enzyme Inhibitors; Female; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pregnancy; Rats; Rats, Sprague-Dawley; Time Factors; Uterine Artery; Vasoconstriction; Vasodilation; Vasodilator Agents	2010
Angiotensin-(1-7) blockade attenuates captopril- or hydralazine-induced cardiovascular protection in spontaneously hypertensive rats treated with NG-nitro-L-arginine methyl ester. Journal of cardiovascular pharmacology, 2011, Volume: 57, Issue:5 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Brain; Captopril; Cytokines; Heart; Hydralazine; Hypertension; In Vitro Techniques; Insulin; Kidney; Leptin; Male; Myocardial Contraction; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Perfusion; Proteinuria; Rats; Rats, Inbred SHR; Ventricular Function, Left	2011
Vaccination against the angiotensin type 1 receptor for the prevention of L-NAME-induced nephropathy. Hypertension research : official journal of the Japanese Society of Hypertension, 2012, Volume: 35, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Enzyme Inhibitors; Hydralazine; Kidney Diseases; Kidney Glomerulus; Male; Membrane Proteins; NG-Nitroarginine Methyl Ester; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Tetrazoles; Vaccines	2012
Diesel exhaust induced pulmonary and cardiovascular impairment: the role of hypertension intervention. Toxicology and applied pharmacology, 2013, Apr-15, Volume: 268, Issue:2 Topics: Albumins; Animals; Atherosclerosis; Cardiovascular Diseases; Hydralazine; Hypertension; Lung Diseases; Male; Myocardial Contraction; NG-Nitroarginine Methyl Ester; Platelet Aggregation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vehicle Emissions	2013
Dual NEP/ECE inhibition improves endothelial function in mesenteric resistance arteries of 32-week-old SHR. Hypertension research : official journal of the Japanese Society of Hypertension, 2017, Volume: 40, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzazepines; Bosentan; Endothelin-Converting Enzymes; Endothelium, Vascular; Enzyme Inhibitors; Hydralazine; Hypertension; Losartan; Mesenteric Arteries; Muscle Contraction; Neprilysin; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Protease Inhibitors; Rats; Rats, Inbred SHR; Sulfonamides; Vascular Resistance	2017
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a "2-Hit" Murine Model. Journal of the American Heart Association, 2023, 02-21, Volume: 12, Issue:4 Topics: Animals; Disease Models, Animal; Drinking Water; Heart Failure; Hydralazine; Male; Mice; Mice, Inbred C57BL; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Sodium Nitrite; Stroke Volume	2023